Newer Drug May Prolong Lymphoma Remission

WEDNESDAY, Oct. 4, 2017 — A newer drug may beat the standard treatment when it comes to battling the blood cancer follicular lymphoma, a clinical trial suggests.
Follicular lymphoma is one type of non-Hodgkin lymphoma, a group of cancers that arise…
Source: Topamax